EUCTR2011-002667-14-CZ进行中（未招募）1 期
Effect of vaccination in patients with recurrent respiratory papillomatosis– can we improve the quality of life of these patients?
Institute of Hematology and Blood Transfusion0 个研究点目标入组 50 人开始时间: 2011年6月30日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •Patients with RRP which sign the informed consent form with both parts of the study will be enrolled.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 40
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 10
排除标准
- •Patients who experience severe side effects of vaccination after the first or second dose will not be vaccinated with the third dose and they will be excluded from the study. Patients who will not receive all three doses within one year and 30 days will be also excluded.
研究者
相似试验
已完成
不适用
Therapeutic vaccination in patients with chronic hepatitis C genotype 1 using four courses of 8 + 6 + 6 + 6 intramuscular injections of 50 µg E1y at 3 week intervals: a multicenter, 3:1 randomized, double-blind, placebo-controlled, parallel-group study over 157 weeks in 122 patientsHepatitisISRCTN71794661Innogenetics NV (Belgium)122
招募中
1 期
VEGFR1/2 Peptide Vaccine in Patients with Recurrent, Progressive and Refractory Brain TumorsRecurrent, Progressive and Refractory Brain Tumors(hemangiopericytoma, hemangioblastoma, WHO grade II or III meningioma, chordoma, ependymoma)JPRN-UMIN000029005Keio university school of medicine20
进行中（未招募）
不适用
To understand the effect of booster dose vaccine on covid inadequate/negative antibody auto immune negative patientsCTRI/2021/12/038928Dr Padmanabha Shenoy
进行中（未招募）
1 期
SARS-CoV-2 vaccination response in patients with haematologicaldiseaseEUCTR2021-001107-33-NLMUMC743
进行中（未招募）
1 期
Immunological responses after concomitant vaccination with the yellow fever-vaccine and the TBE-vaccine, or JE-vaccinePrevention of TBE or Japanece encephalitis by co-vaccination with the yellow fever vaccineEUCTR2017-002137-32-SEHans-Gustaf Ljunggren140